Navidea Biopharmaceuticals Announces PDUFA Goal Date for Lymphoseek® New Drug Application Resubmission Nov 13, 2012
Navidea Awarded SBIR Grant from the NIH for Development of Radio-Immuno-Guided Surgery (RIGS) Agent Aimed at Detecting Metastatic Cancer Sep 20, 2012
Navidea Biopharmaceuticals Announces the Presentation of Lymphoseek® Phase 3 Meta-Analysis Data at the 32nd Congress of the European Society of Surgical Oncology Sep 20, 2012
Navidea Biopharmaceuticals Announces Enrollment of First Subject in Phase 2 Trial of NAV4694 as an Aid in Diagnosing Alzheimer’s Disease Sep 18, 2012
Navidea Biopharmaceuticals Receives Complete Response Letter from FDA for Lymphoseek® NDA Due to Manufacturing Deficiencies Sep 10, 2012
Navidea Biopharmaceuticals Names Pharma Industry Veteran Cornelia Reininger, M.D., Ph.D., as Chief Medical Officer Sep 5, 2012
